Sfoglia per AUTORE
RUSSO D
Collezione AO Cuneo

  

Items : 10

[ANMCO Position paper: Cardiovascular disease in women - prevention, diagnosis, treatment and organization of care]. in Giornale italiano di cardiologia (2006) / G Ital Cardiol (Rome). 2022 Oct;23(10):775-792. doi: 10.1714/3881.38644.

2022
AO Cuneo
AO Ordine Mauriziano

Gulizia MM; Colivicchi F; Oliva F; De Luca L; Gabrielli D; Russo G; Russo MG; Scardovi AB; Resta M; Riva L; Rossini R; Russo D; Martinis F; Marzullo R; Masciocco G; Rakar S; Parrini I; Marcantoni L; Lucà F; Ingianni N; Giubilato S; Giuffrida C; Gil Ad V; Frongillo D; Fiscella D; De Angelis MC; Enea I; Di Fusco SA; Caforio ALP; et alii...

Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 May;27(5):406.e1-406.e11. doi: 10.1016/j.jtct.2020.11.021. Epub 2021 Feb

2021
AO Cuneo
AOU Città della Salute di Torino

Bonifazi F; Ciceri F; Miccichè S; Mangione I; Pollichieni S; Mammoliti S; Gallina AM; Patriarca F; Carella AM; Luppi M; Olivieri A; Martino M; Carluccio P; Celeghini I; Andreani M; Lamparelli T; La Rocca U; Milone G; Chiusolo P; Borghero C; Papalinetti G; Guidi S; Saporiti G; Zallio F; Fagioli F; Farina L; Russo D; Arcese W; Benedetti F; et alii...

Second primary malignancy in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2021 Apr;193(2):356-368. doi: 10.1111/bjh.17192. Epub 2020 Nov 21.

2021
AO Cuneo
AOU Città della Salute di Torino

Iurlo A; Cavo M; Russo D; Breccia M; Vianelli N; Lemoli RM; Semenzato G; Krampera M; Cuneo A; Catani L; Pane F; Markovic U; Stella R; Trawinska MM; Cattaneo D; D'Amore F; Scaffidi L; Martino B; Latagliata R; Gandolfi L; Auteri G; Bartoletti D; Bosi C; Isidori A; Pugliese N; Crugnola M; Heidel FH; Cavazzini F; Binotto G; et alii...

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties. in Bone marrow transplantation / Bone Marrow Transplant. 2019 Jan;54(1):44-52. doi: 10.1038/s41409-018-0207-4. Epub 2018 May 4.

2019
AO Cuneo

Schetelig J; Montoto S; Fox CP; Kröger N; Schaap M; Canepari ME; Stilgenbauer S; Bunjes D; Bethge W; Wulf G; Berg T; Labussiere-Wallet H; Durakovic N; van Gelder M; Passweg J; Ljungman P; Russo D; Finke J; Andersen NS; Schoemans H; Scortechini I; Müller L; Vandenberghe E; Niederwieser D; Cornelissen J; Scheid C; Nagler A; Boumendil A; Sobh M; et alii...

Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. in The Lancet. Haematology / Lancet Haematol. 2019 Feb;6(2):e89-e99. doi: 10.1016/S2352-3026(18)30214-X.

2019
AO Cuneo

Heinzelmann M; Benedetti F; Milone G; Benedetti E; Russo D; Sierra J; Sorasio R; Ferra C; Finke J; Guidi S; Cimminiello M; Carella AM; Sureda A; Herrera P; Bethge W; Messina G; Risitano AM; Selleri C; Nagler A; Zallio F; Patriarca F; Sessa M; Wolschke C; Solano C; Bonifazi F; Pastore D; Jurado M; Terruzzi E; Narni F; et alii...

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Città della Salute di Torino
AO Cuneo
AOU Alessandria
AOU Novara

Soverini S; Vigneri P; Rosti G; Bonifacio M; Breccia M; Castagnetti F; Saglio G; Pane F; Russo D; Trabacchi E; Spadano R; Stagno F; Tiribelli M; Tomassetti S; Sancetta R; Sica S; Salvucci M; Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Miggiano MC; Montefusco E; Musolino C; Palmieri F; Malagola M; Melpignano A; Martino B; Marasca R; et alii...

Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis. in Oncotarget / Oncotarget. 2017 Jun 27;8(45):79073-79086. doi: 10.18632/oncotarget.18674. eCollection 2017 Oct 3.

2017
AOU Città della Salute di Torino
AO Cuneo

Cuneo A; Cavo M; Vianelli N; Breccia M; Bacchi Reggiani ML; Merli F; Fanin R; Lemoli RM; Vitolo U; Di Raimondo F; Aversa F; Catani L; Sabattini E; Spinsanti M; De Matteis G; Anaclerico B; Cerqui E; de Marchi F; Scaffidi L; Di Veroli A; Latagliata R; Bosi C; Crugnola M; Ibatici A; Cavazzini F; Tieghi A; Bergamaschi M; Polverelli N; D'Adda M; et alii...

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. in The New England journal of medicine / N Engl J Med. 2016 Jan 7;374(1):43-53. doi: 10.1056/NEJMoa1506002.

2016
AO Cuneo
AOU Alessandria

Kröger N; Bonifazi F; Ruutu T; Ayuk F; Völp A; Narni F; Terruzzi E; Jurado M; Pastore D; Heinzelmann M; Benedetti F; Milone G; Petrini M; Russo D; Sierra J; Ferra C; Mordini N; Finke J; Guidi S; Cimminiello M; Carella AM; Duarte R; Pérez de Oteiza J; Bethge W; Messina G; Risitano A; Selleri C; Nagler A; Pini M; et alii...

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2015 Nov;16(15):1525-1536. doi: 10.1016/S1470-2045(15)00200-4. Epub 2015 Sep 28.

2015
AO Cuneo
AOU Alessandria

Bosi A; Bacigalupo A; Oldani E; Marfisi RM; Mordini N; Scimè R; Torelli GF; Corradini P; Alessandrino EP; Russo D; Nagler A; Marotta G; Carella AM; Arcese W; Terruzzi E; Saporiti G; Pini M; Risitano AM; Patriarca F; Guidi S; Pastore D; Chiusolo P; Raimondi R; Montanari M; Milone G; Santarone S; Cavattoni I; Busca A; Bruno B; et alii...

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2014 Jun;20(6):872-80. doi: 10.1016/j.bbmt.2014.03.004. Epub 2014 Mar

2014
AO Cuneo
AOU Città della Salute di Torino

Locasciulli A; Rambaldi A; Bacigalupo A; Bandini G; Arcese W; Busca A; Bosi A; Majolino I; Sica S; Castagnola E; Bonini A; Olivieri A; Vallisa D; Milone G; Pisapia G; Falcioni S; Onida F; Vacca A; Pastore D; Mordini N; Russo D; Risitano AM; Prete A; Musso M; Baronciani D; Patriarca F; Irrera G; Bruno B; Zucchetti E; et alii...